Shi-Wen Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shi-Wen Jiang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Karl C. Podratz
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA
3 shared publicationsSean C. Dowdy
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA
3 shared publicationsBobbie S. Gostout
Department of Obstetrics and Gynecology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
1 shared publicationDavid I. Smith
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
1 shared publicationMiguel A. Trujillo
Endocrine Research Unit (S.-W.J., M.A.T., N.L.E.), Minnesota 55905
1 shared publicationMonica B. Jones
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA
1 shared publication
Latest Publications
- 1 May 2007
- Published by Elsevier in Gynecologic Oncology
- Vol. 105 (2) , 493-500
Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells
- 1 May 2007
- Published by Elsevier in Gynecologic Oncology
- Vol. 105 (2) , 493-500
Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells
- 1 October 2006
- Published by Elsevier in Gynecologic Oncology
- Vol. 103 (1) , 321-328
hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications
- 1 October 2006
- Published by Elsevier in Gynecologic Oncology
- Vol. 103 (1) , 321-328
hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications
- 1 October 2005
- Published by Elsevier in Gynecologic Oncology
- Vol. 99 (1) , 126-134
Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines
- 1 October 2005
- Published by Elsevier in Gynecologic Oncology
- Vol. 99 (1) , 126-134
Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines
- Open Access
- 1 August 1997
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 11 (9) , 1223-1232
Human Chorionic Somatomammotropin Enhancer Function Is Mediated by Cooperative Binding of TEF-1 and CSEF-1 to Multiple, Low-Affinity Binding Sites
The human chorionic somatomammotropin gene enhancer (CSEn) is composed of multiple enhansons (Enh) that share sequence similarities with those of the simian virus, SV40 enhancer (SVEn). The sequence homology includes two GT-IIC-like (Enh1 and Enh4) and three SphI/II-like enhansons (Enh2, Enh3, and Enh5). We previously showed that transcription enhancer factor 1 (TEF-1) and a 30-kDa placental-specific factor, chorionic somatomammotropin enhancer factor 1 (CSEF-1), bind to Enh4, which plays an essential role in enhancer function. In this study, we demonstrate that TEF-1 and CSEF-1 bind specifically to all the other GT-IIC- and SphI/II-like elements within CSEn with a broad range of binding affinities that vary between 0.005 and 0.15 that of Enh4. Each individual concatenated enhanson was able to stimulate hCS promoter activity in an orientation-independent manner in choriocarcinoma cells (BeWo) with an observed stimulation that was directly proportional to its relative binding affinity for TEF-1 and CSEF-1. These results indicate that CSEn function results from the cooperative interaction of TEF-1 and/or CSEF-1 binding to multiple, low-affinity GT-IIC- and SphI/II-like enhansons within the enhancer.
- 1 August 1997
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 11 (9) , 1223-1232
Open AccessHuman Chorionic Somatomammotropin Enhancer Function Is Mediated by Cooperative Binding of TEF-1 and CSEF-1 to Multiple, Low-Affinity Binding Sites
The human chorionic somatomammotropin gene enhancer (CSEn) is composed of multiple enhansons (Enh) that share sequence similarities with those of the simian virus, SV40 enhancer (SVEn). The sequence homology includes two GT-IIC-like (Enh1 and Enh4) and three SphI/II-like enhansons (Enh2, Enh3, and Enh5). We previously showed that transcription enhancer factor 1 (TEF-1) and a 30-kDa placental-specific factor, chorionic somatomammotropin enhancer factor 1 (CSEF-1), bind to Enh4, which plays an essential role in enhancer function. In this study, we demonstrate that TEF-1 and CSEF-1 bind specifically to all the other GT-IIC- and SphI/II-like elements within CSEn with a broad range of binding affinities that vary between 0.005 and 0.15 that of Enh4. Each individual concatenated enhanson was able to stimulate hCS promoter activity in an orientation-independent manner in choriocarcinoma cells (BeWo) with an observed stimulation that was directly proportional to its relative binding affinity for TEF-1 and CSEF-1. These results indicate that CSEn function results from the cooperative interaction of TEF-1 and/or CSEF-1 binding to multiple, low-affinity GT-IIC- and SphI/II-like enhansons within the enhancer.